Thanks rjs, that makes sense. So they need the FDA protocol that GNBT submitted to FDA to be approved. Next question, since the deal is based on this new tidbit, does that mean GNBT does not get the $2.5M until we get the FDA protocol approval? It know it said/says 2 weeks, but how can that be if one of the new conditions is not satisfied yet? Maybe the $2.5M is a deposit, but wouldn't Bintai want it back if the FDA does not approve our IND submission? And as a side note, there is NO REASON to believe the FDA will not approve it since they responded to the written request with comments several weeks back.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.